newsfilter
← Latest News
GlobeNewswire·

Opus Genetics to Participate in Leading Medical Conferences in May 2026

RESEARCH TRIANGLE PARK, N.C., April 27, 2026 (GLOBE NEWSWIRE) -- Opus Genetics (NASDAQ:IRD) ("Opus Genetics" or the "Company"), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and